Hims & Hers Health first-quarter revenue more than doubled as subscribers rose 38%, while its second-quarter sales outlook ...

Khloe Kardashian gave fans a peek inside her ultra-sleek pantry to promote her Khloud Protein Popcorn, but it wasn't the ...

Weight loss medications and bariatric surgery used to be considered last-resort options, but now, they’re everywhere. More ...

Semaglutide, the blockbuster drug better known by brand names like Ozempic and Wegovy, has now shown significant promise in ...

AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Amanda Hoelscher, a licensed nurse practitioner, joined Good Day to explain why the FDA has ordered some pharmacies to stop selling “copycat” versions of Ozempic.

Hims & Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer. The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Decades of studies and statistics have shown that women are consistently held back in the workplace because of their gender.

You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...

The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...